Alpha-1 Antitrypsin Replacement in Patients With COPD.

Alpha-1 Antitrypsin Replacement in Patients With COPD.
复制标题

COPD 患者的 Alpha-1 抗胰蛋白酶替代疗法。

DOI:
--
复制
发表时间:
2019
期刊:
P & T : a peer-reviewed journal for formulary management
影响因子:
--
通讯作者:
M. Malesker
M. Malesker
中科院分区:
--
文献类型:
--
作者:
A. Wells;A. Woods;D. Hilleman;M. Malesker

文献摘要

被引文献

相似文献

慢性阻塞性肺疾病可归因于遗传条件和易感性等因素。α-1抗胰蛋白酶缺乏症(AATD)是COPD发生和进展的重要风险因素,鼓励对所有COPD或成人发作哮喘患者进行积极筛查。
Chronic obstructive pulmonary disease can be attributed to genetic conditions and predispositions, among other factors. Alpha-1 antitrypsin deficiency (AATD) is a significant risk factor for COPD development and progression, and aggressive screening for all patients with COPD or adult-onset asthma is encouraged.